LR-ESHAP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LR-ESHAP, covering 2020-01-10 to 2020-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]